Global Clinical Trials Outsourcing Market 2023-2029

March 2023 | 60 pages | ID: GEC626A4AB5BEN
Gen Consulting Company

Abstracts

Clinical trials outsourcing refers to the process of contracting out clinical trial-related activities to external service providers. These service providers can include Contract Research Organizations (CROs), academic research institutions, and specialized vendors who provide various clinical trial services, such as patient recruitment, site monitoring, data management, statistical analysis or regulatory filing. Outsourcing clinical trials allows pharmaceutical, biotechnology, and medical device companies to focus on their core business while accessing the expertise and resources of specialized service providers. The global clinical trials outsourcing market size is projected to grow by USD 20.4 billion from 2023 to 2029, registering a CAGR of 6.68 percent, according to the latest market data.

The report covers market size and growth, segmentation, regional breakdowns, competitive landscape, trends and strategies for global clinical trials outsourcing market. It presents a quantitative analysis of the market to enable stakeholders to capitalize on the prevailing market opportunities. The report also identifies top segments for opportunities and strategies based on market trends and leading competitors’ approaches.

This industry report offers market estimates and forecasts of the global market, followed by a detailed analysis of the phase, application, end user, and region. The global market for clinical trials outsourcing can be segmented by phase: phase I, phase III, phase III, phase IV. Globally, the phase III segment made up the largest share of the clinical trials outsourcing market. Clinical trials outsourcing market is further segmented by application: cancer, cardiovascular diseases, nervous system diseases, infectious diseases, musculoskeletal disease, gastroenterology diseases, others. The cancer segment captured the largest share of the market in 2022. Based on end user, the clinical trials outsourcing market is segmented into: small & mid-size enterprises, large enterprises. According to the research, the small & mid-size enterprises segment had the largest share in the global clinical trials outsourcing market. On the basis of region, the clinical trials outsourcing market also can be divided into: North America, Europe, Asia-Pacific, MEA (Middle East and Africa), Latin America. North America held the largest revenue share in 2022.

Market Segmentation
By phase: phase I, phase III, phase III, phase IV
By application: cancer, cardiovascular diseases, nervous system diseases, infectious diseases, musculoskeletal disease, gastroenterology diseases, others
By end user: small & mid-size enterprises, large enterprises
By region: North America, Europe, Asia-Pacific, MEA (Middle East and Africa), Latin America

The global clinical trials outsourcing market report offers detailed information on several market vendors, including IQVIA Holdings, Inc., Laboratory Corp of America Holdings, Charles River Laboratory Inc., Wuxi AppTec Co., Ltd., Syneos Health Inc., Thermo Fisher Scientific Inc., Icon plc, among others. In this report, key players and their strategies are thoroughly analyzed to understand the competitive outlook of the market.
*REQUEST FREE SAMPLE TO GET A COMPLETE LIST OF COMPANIES

Scope of the Report
To analyze and forecast the market size of the global clinical trials outsourcing market.
To classify and forecast the global clinical trials outsourcing market based on phase, application, end user, region.
To identify drivers and challenges for the global clinical trials outsourcing market.
To examine competitive developments such as mergers & acquisitions, agreements, collaborations and partnerships, etc., in the global clinical trials outsourcing market.
To identify and analyze the profile of leading players operating in the global clinical trials outsourcing market.

Why Choose This Report
Gain a reliable outlook of the global clinical trials outsourcing market forecasts from 2023 to 2029 across scenarios.
Identify growth segments for investment.
Stay ahead of competitors through company profiles and market data.
The market estimate for ease of analysis across scenarios in Excel format.
Strategy consulting and research support for three months.
Print authentication provided for the single-user license.

Contents

PART 1. INTRODUCTION

Report description
Objectives of the study
Market segment
Years considered for the report
Currency
Key target audience

PART 2. METHODOLOGY

PART 3. EXECUTIVE SUMMARY

PART 4. MARKET OVERVIEW

Introduction
Drivers
Restraints

PART 5. MARKET BREAKDOWN BY PHASE

Phase I
Phase III
Phase III
Phase IV

PART 6. MARKET BREAKDOWN BY APPLICATION

Cancer
Cardiovascular diseases
Nervous system diseases
Infectious diseases
Musculoskeletal disease
Gastroenterology diseases
Others

PART 7. MARKET BREAKDOWN BY END USER

Small & mid-size enterprises
Large enterprises

PART 8. MARKET BREAKDOWN BY REGION

North America
Europe
Asia-Pacific
MEA (Middle East and Africa)
Latin America

PART 9. KEY COMPANIES

IQVIA Holdings, Inc.
Laboratory Corp of America Holdings
Charles River Laboratory Inc.
Wuxi AppTec Co., Ltd.
Syneos Health Inc.
Thermo Fisher Scientific Inc.
Icon plc

DISCLAIMER